09:43 AM EST, 11/03/2025 (MT Newswires) -- Cogent Biosciences ( COGT ) reported a Q3 net loss Monday of $80.9 million, wider than a loss of $70.6 million a year earlier.

Analysts polled by FactSet expected a net loss of $75 million.

As expected, no revenue for the quarter ended Sept. 30 was reported.

As of Sept. 30, the company said it had $390.9 million in cash, cash equivalents and marketable securities, which it said was sufficient to fund operations into 2027.

Price: 16.35, Change: +0.05, Percent Change: +0.31